ALTIMMUNE, INC. Revenue
ALTIMMUNE, INC. (ALT) reported Revenue of $41.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-12
- ALTIMMUNE, INC. revenues for the quarter ending 2025-12-31 was $26.00K, a 420.00% increase year-over-year.
- ALTIMMUNE, INC. revenues for the quarter ending 2025-09-30 was $5.00K, a 0.00% change year-over-year.
- ALTIMMUNE, INC. revenues for the quarter ending 2025-06-30 was $5.00K, a 0.00% change year-over-year.
- ALTIMMUNE, INC. revenues for the quarter ending 2025-03-31 was $5.00K, a 0.00% change year-over-year.
- ALTIMMUNE, INC. revenues for fiscal 2025 was $41.00K, a 105.00% increase from fiscal 2024.
- ALTIMMUNE, INC. revenues for fiscal 2024 was $20.00K, a 95.31% decline from fiscal 2023.
- ALTIMMUNE, INC. revenues for fiscal 2023 was $426.00K.
- ALTIMMUNE, INC. revenues for fiscal 2022 was -$68.00K, a 101.54% decline from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2025-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $31.00K derived: sum of 2 quarters · filed 2026-03-06 | $36.00K derived: sum of 3 quarters · filed 2026-08-12 | $41.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-06 | $10.00K derived: sum of 2 quarters · filed 2026-08-12 | $15.00K 10-Q · filed 2025-11-06 | $20.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $5.00K 10-Q · filed 2026-08-12 | $10.00K 10-Q · filed 2026-08-12 | $15.00K derived: sum of 3 quarters · filed 2026-08-12 | $20.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $5.00K 10-Q · filed 2026-05-13 | $10.00K derived: sum of 2 quarters · filed 2026-05-13 | $15.00K derived: sum of 3 quarters · filed 2026-05-13 | $20.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $10.00K derived: sum of 2 quarters · filed 2026-03-06 | $15.00K derived: sum of 3 quarters · filed 2026-03-06 | $20.00K 10-K · filed 2026-03-06 |
| 2024-09-30 | $5.00K 10-Q · filed 2025-11-06 | $10.00K derived: sum of 2 quarters · filed 2025-11-06 | $15.00K 10-Q · filed 2025-11-06 | $52.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $5.00K 10-Q · filed 2025-08-12 | $10.00K 10-Q · filed 2025-08-12 | $47.00K derived: sum of 3 quarters · filed 2025-08-12 | $409.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-13 | $42.00K derived: sum of 2 quarters · filed 2025-05-13 | $404.00K derived: sum of 3 quarters · filed 2025-05-13 | $410.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $399.00K derived: sum of 2 quarters · filed 2025-02-27 | $405.00K derived: sum of 3 quarters · filed 2025-02-27 | $426.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $362.00K 10-Q · filed 2024-11-12 | $368.00K derived: sum of 2 quarters · filed 2024-11-12 | $389.00K 10-Q · filed 2024-11-12 | $279.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $6.00K 10-Q · filed 2024-08-08 | $27.00K 10-Q · filed 2024-08-08 | -$83.00K derived: sum of 3 quarters · filed 2024-08-08 | -$81.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $21.00K 10-Q · filed 2024-05-09 | -$89.00K derived: sum of 2 quarters · filed 2024-05-09 | -$87.00K derived: sum of 3 quarters · filed 2024-05-09 | -$79.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$108.00K derived: sum of 2 quarters · filed 2024-03-27 | -$100.00K derived: sum of 3 quarters · filed 2024-03-27 | -$68.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $2.00K 10-Q · filed 2023-11-07 | $10.00K derived: sum of 2 quarters · filed 2023-11-07 | $42.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $8.00K 10-Q · filed 2023-08-10 | $40.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $32.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $4.41M 10-K · filed 2023-02-28 | |||
| 2011-12-31 | $24.27M 10-K · filed 2012-03-08 | |||
| 2010-12-31 | $20.99M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |